Guo-Kang Sun

DOK6 promoter methylation serves as a potential biomarker affecting prognosis in de novo acute myeloid leukemia

J. Qian, Jiang Lin, Jichun Ma, 2019, Cancer medicine.

Diagnosis of Osteoarthritis Subtypes with Blood Biomarkers

H. Ouyang, Bing-bing Wu, M. E. Paul, 2018, bioRxiv.

Dysregulation of LINC00324 associated with methylation facilitates leukemogenesis in de novo acute myeloid leukemia

Dong-ming Yao, Zi-jun Xu, L. Tang, 2022, International journal of laboratory hematology.

Abnormal expression and methylation of PRR34‐AS1 are associated with adverse outcomes in acute myeloid leukemia

J. Qian, Jiang Lin, Jichun Ma, 2021, Cancer medicine.

Down-regulation of miR-29c is a prognostic biomarker in acute myeloid leukemia and can reduce the sensitivity of leukemic cells to decitabine

J. Qian, Jiang Lin, Jichun Ma, 2019, Cancer Cell International.

Down-regulation of miR-29c is a prognostic biomarker in acute myeloid leukemia and can reduce the sensitivity of leukemic cells to decitabine

J. Qian, Jiang Lin, Jichun Ma, 2019, Cancer Cell International.